Cerebral Palsy, Development Delay, Genetic Disease, Spina Bifida, Spinal Cord Injuries, Spinal Muscular Atrophy
Conditions
Brief summary
For children who use a power wheelchair, a powered wheelchair standing device (PWSD) may be considered for daily use. A PWSD allows a child to electronically move between sitting and standing and can be driven in either position. Existing published PWSD research in pediatrics is limited to boys with Duchenne muscular dystrophy (DMD).(1, 2) While these studies provide some insights into PWSD use in boys with DMD, they do not reflect PWSD use in children with other conditions. The purpose of this exploratory study is to determine the feasibility of a research protocol exploring use of a PWSD in children who have neurodevelopmental conditions other than DMD.
Interventions
DEVICEPower Wheelchair Standing Device
A power wheelchair standing device is a power wheelchair that allows a child to electronically move between sitting and standing. It can be driven in either position. The Permobil F5 Corpus VS is the specific power wheelchair standing device to be used in this study.
Sponsors
Grand Valley State University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
1. Is 5-17 years of age. NOTE: Participants must be under 18 for the duration of the study. 2. Diagnosed with a neurodevelopmental condition resulting in an inability to functionally ambulate. 3. Can safely assume and maintain a supported standing position 4. Has sufficient upper extremity and function to safely use a PWSD 5. Can communicate pain or discomfort through verbalization, vocalization, use of augmented communication, etc. 6. Can safely use the PWSD in areas of their home 7. Has at least one parent/caregiver who is able to converse in English and actively participate in a device-use education provided in English 8. The PerMobil PWSD can be set up to meet the child's specific needs 9. Medical Clearance to trial the PWSD 10. Participants must reside in Michigan
Exclusion criteria
1. Has a diagnosis of Duchenne muscular dystrophy. 2. Any reason that it would not be safe for the child to use a PWSD
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Participation in children | 2 years | Does using a PWSD increase participation in children who have neurodevelopmental conditions other than DMD? |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Parental/caregiver perceptions | 2 years | Does using a PWSD influence parental/caregiver perceptions of their child's emotional/behavioral status? |
| Children's perceptions | 2 years | For children who are able to respond to questions and participate in an interview using either verbal or augmented communication, does using a PWSD influence their own perceptions of their emotional/behavioral status? |
Countries
United States
Outcome results
None listed